Individual radiosensitivity does not correlate with radiation-induced apoptosis in lymphoblastoid cell lines or CD3+ lymphocytes

Strahlentherapie und Onkologie

Volumn 181, Issue 5, 2005, Pages 326-335

  Wistop, Anja ^a   Keller, Ulrike ^a   Sprung, Carl N ^b   Grabenbauer, Gerhard G ^a   Sauer, Rolf ^a   Distel, Luitpold V R ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Hypersensitivity; Individual radiosensitivity; LCLS; Lymphocytes; Radiation induced apoptosis

Indexed keywords

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN CELL; IMAGE ANALYSIS; LYMPHOBLASTOID CELL; LYMPHOCYTE; NICK END LABELING; RADIATION DOSE; RADIOSENSITIVITY;

ANTIGENS, CD3; APOPTOSIS; ATAXIA TELANGIECTASIA; BLOOD DONORS; CELL LINE; CELL LINE, TRANSFORMED; HERPESVIRUS 4, HUMAN; HUMANS; IN SITU NICK-END LABELING; RADIATION TOLERANCE; REFERENCE VALUES; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 20044392674     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-005-1372-0     Document Type: Article

References (39)

1. Barber JB, West CM, Kiltie AE, et al. Detection of individual differences in radiation-induced apoptosis of peripheral blood lymphocytes in normal individuals, ataxia telangiectasia homozygotes and heterozygotes, and breast cancer patients after radiotherapy. Radiat Res 2000;153:570-8.
2. Belka C, Betsch A, Marini P, et al. [Death inducing ligands in combination with ionizing radiation: objective and current knowledge.] Strahlenther Onkol2003;179:141-51.
3. Bremer M, Schindler D, Gross M, et al. Fanconi's anemia and clinical radio-sensitivity report on two adult patients with locally advanced solid tumors treated by radiotherapy. Strahlenther Onkol 2003;179:748-53.
4. Crompton NE, Emery GC, Shi Y, et al. Radiation-induced genetic instability: no association with changes in radiosensitivity or cell cycle checkpoints in C3H 10T1/2 mouse fibroblasts. Radiat Environ Biophys 1998;36:255-9.
5. Crompton NE, Miralbell R, Rutz HP, et al. Altered apoptotic profiles in irradiated patients with increased toxicity. Int J Radiat Oncol Biol Phys 1999;45:707-14.
6. Crompton NE, Ozsahin M. A versatile and rapid assay of radiosensitivity of peripheral blood leukocytes based on DNA and surface-marker assessment of cytotoxicity. Radiat Res 1997;147:55-60.
7. Crompton NE, Shi YQ, Emery GC, et al. Sources of variation in patient response to radiation treatment. Int J Radiat Oncol Biol Phys 2001;49:547-54.
8. Crompton NE, Shi YQ, Wuergler F, et al. A single low dose of X-rays induces high frequencies of genetic instability (aneuploidy) and heritable damage (apoptosis), dependent on cell type and p53 status. Mutat Res 2002;517:173-86.
9. D'Andrea AD, Grompe M. The Fanconi anaemia/BRCA pathway. Nat Rev Cancer 2003;3:23-34.
10. Dikomey E, Brammer I. Relationship between cellular radiosensitivity and non-repaired double-strand breaks studied for different growth states, dose rates and plating conditions in a normal human fibroblast line. Int J Radiat Biol 2000;76:773-81.
11. Dikomey E, Brammer I, Johansen J, et al. Relationship between DNA double-strand breaks, cell killing, and fibrosis studied in confluent skin fibroblasts derived from breast cancer patients. Int J Radiat Oncol Biol Phys 2000;46:481-90.
12. Distel L, Neubauer S, Varan R, et al. Fatal toxicity following radio- and chemotherapy of medulloblastoma in a child with unrecognized Nijmegen breakage syndrome. Med Pediatr Oncol 2003;41:44-8.
13. Girard PM, Foray N, Stumm M, et al. Radiosensitivity in Nijmegen breakage syndrome cells is attributable to a repair defect and not cell cycle checkpoint defects. Cancer Res 2000;60:4881-8.
14. Hart RM, Kimler BF, Evans RG, et al. Radiotherapeutic management of medulloblastoma in a pediatric patient with ataxia telangiectasia. Int J Radiat Oncol Biol Phys 1987;13:1237-40.
15. Howlett NG, Taniguchi T, Olson S, et al. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 2002;297:606-9.
16. Jung H, Beck-Bornholdt HP, Svoboda V, et al. Quantification of late complications after radiation therapy. Radiother Oncol 2001;61:233-46.
17. Keller U, Grabenbauer G, Kuechler A, et al. Radiation sensitivity testing by FISH: how many metaphases have to be analysed? Int J Radiat Biol 2004;80:615-20.
18. Keller U, Kuechler A, Liehr T, et al. Impact of various parameters in detecting chromosomal aberrations by FISH to describe radiosensitivity. Strahlenther Onkol 2004;180:289-96.
19. Kuechler A, Neubauer S, Grabenbauer GG, et al. Is 24-color FISH detection of in-vitro radiation-induced chromosomal aberrations suited to determine individual intrinsic radiosensitivity? Strahlenther Onkol 2002;178:209-15.
20. Kurz EU, Lees-Miller SP. DNA damage-induced activation of ATM and ATM-dependent signaling pathways. DNA Repair (Amst) 2004;3:889-900.
21. Meijer AE, Zhivotovsky B, Lewensohn R. Epstein-Barr virus-transformed lymphoblastoid cell lines of ataxia telangiectasia patients are defective in X-ray-induced apoptosis. Int J Radiat Biol 1999;75:709-16.
22. Menz R, Andres R, Larsson B, et al. Biological dosimetry: the potential use of radiation-induced apoptosis in human T-lymphocytes. Radiat Environ Biophys 1997;36:175-81.
23. Neubauer S, Arutyunyan R, Stumm M, et al. Radiosensitivity of ataxia telangiectasia and Nijmegen breakage syndrome homozygotes and heterozygotes as determined by three-color FISH chromosome painting. Radiat Res 2002;157:312-21.
24. Neubauer S, Dunst J, Gebhart E. The impact of complex chromosomal rearrangements on the detection of radiosensitivity in cancer patients. Radiother Oncol 1997;43:189-95.
25. O'Driscoll M, Cerosaletti KM, Girard PM, et al. DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. Mol Cell 2001;8:1175-85.
26. O'Driscoll M, Jeggo P. Immunological disorders and DNA repair. Mutat Res 2002;509:109-26.
27. Oya N, Zolzer F, Werner F, et al. Effects of serum starvation on radiosensitivity, proliferation and apoptosis in four human tumor cell lines with different p53 status. Strahlenther Onkol 2003;179:99-106.
28. Riballo E, Doherty AJ, Dai Y, et al. Cellular and biochemical impact of a mutation in DNA ligase IV conferring clinical radiosensitivity. J Biol Chem 2001;276:31124-32.
29. Russell NS, Begg AC. Editorial radiotherapy and oncology 2002: predictive assays for normal tissue damage. Radiother Oncol 2002;64:125-9.
30. Shi YQ, Li L, Sanal O, et al. High levels of delayed radiation-induced apoptosis observed in lymphoblastoid cell lines from ataxia-telangiectasia patients. Int J Radiat Oncol Biol Phys 2001;49:555-9.
31. Shi YQ, Wuergler FE, Blattmann H, et al. Distinct apoptotic phenotypes induced by radiation and ceramide in both p53-wild-type and p53-mutated lymphoblastoid cells. Radiat Environ Biophys 2001;40:301-8.
32. Shiloh Y. Ataxia-telangiectasia and the Nijmegen breakage syndrome: related disorders but genes apart. Annu Rev Genet 1997;31:635-62.
33. Stewart GS, Maser RS, Stankovic T, et al. The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder. Cell 1999;99:577-87.
34. Tauchi H, Matsuura S, Kobayashi J, et al. Nijmegen breakage syndrome gene, NBS1, and molecular links to factors for genome stability. Oncogene 2002;21:8967-80.
35. Varan R, Seemanova E, Chrzanowska K, et al. Clinical ascertainment of Nijmegen breakage syndrome (NBS) and prevalence of the major mutation, 657del5, in three Slav populations. Eur J Hum Genet 2000;8:900-2.
36. Vineis P. Individual susceptibility to carcinogens. Oncogene 2004;23:6477-83.
37. Wilkins RC, Kutzner BC, Truong M, et al. Analysis of radiation-induced apoptosis in human lymphocytes: flow cytometry using annexin V and propidium iodide versus the neutral comet assay. Cytometry 2002;48:14-9.
38. Wilkins RC, Wilkinson D, Maharaj HP, et al. Differential apoptotic response to ionizing radiation in subpopulations of human white blood cells. Mutat Res 2002;513:27-36.
39. Wood RD, Mitchell M, Sgouros J, et al. Human DNA repair genes. Science 2001;291:1284-9.